Doctis

🧬 The #DocTISProject has officially concluded after six and a half years of collaborative research.

🔬 Its legacy includes major advances in #IMIDs research, valuable molecular datasets and an ongoing innovative #ClinicalTrial.

👉 doctis.eu/doctis-outcome…

#IMID #EUResearch

🔬 Our final interview with the Principal Investigators of #DocTISProject features our Coordinator Dr Sara Marsal from @VHIR_ and @vallhebron.

🎤 Discover her perspective on the project’s achievements, clinical trial and lasting legacy.

👉 doctis.eu/sara-marsal-le…

#IMID #IMIDs

📣 Our #DocTISProject interview series continues.

🎤 @hoheyn from @cnag_eu explains how DocTIS is using advanced #SingleCell #genomics to better understand #IMIDs, improve patient stratification and support more personalised treatment strategies.

👉 doctis.eu/holger-heyn-si…

📢 As part of the #DocTISProject series, we feature Myrsini Gianatsi, Medical Statistician at @cardiffuni.

🔬 Her work helps evaluate new treatment strategies for #IMIDs through innovative #ClinicalTrial design.

👉 doctis.eu/myrsini-gianat…

#MedicalStatistics #IMIDResearch

🧪 As part of the #DocTISProject series, we feature Edgar Angelats, Postdoctoral Scientist at @idibaps.

🔬His work focuses on the #preclinical validation of combinatorial therapies identified through #SystemsBiology approaches for #IMIDs.

📖 doctis.eu/edgar-angelats…

#IMID